CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • ASCO 2015: Report from Day 1

    A day for travel and educational sessions at the American Society of Clinical Oncology (ASCO).

    May 29, 2015| CRI Staff
  • ASCO 2015: 3 Tips for Patients

    Tips for patients looking to follow the breaking cancer treatment news from ASCO 2015

    May 29, 2015| Emily Helck
  • ASCO 2015: What to Watch in Immunotherapy

    Curious about what immunotherapy breakthroughs are coming at ASCO? Here’s a preview.

    May 28, 2015| Jill O'Donnell-Tormey, PhD
  • CRI’s Insights for ASCO 2015

    Our expert panel in cancer immunotherapy weighs in on what to look for at this year's meeting.

    May 18, 2015| Jill O'Donnell-Tormey, PhD
  • 2015 International Meeting: Translating Science Into Survival

    Hosted by CRI, CIMT, EATI, and AACR, the Inaugural International Cancer Immunotherapy Conference (CICON) 2015 will bring…

    May 11, 2015| Michelle Liew
  • Watching AACR from Near and Far

    Social media added a new dimension to the conversation at AACR.

    April 24, 2015| Emily Helck
  • AACR 2015: Report from Day 5

    Some lesser-known cell types in the immune response to cancer were discussed on the meeting's final day.

    April 22, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 4

    Spotlight on CAR T cell therapy.

    April 21, 2015| Matthew Tontonoz
  • AACR 2015: Report from Day 3

    Results of two high-profile clinical trials, among others, are covered on the meeting's third day.

    April 20, 2015| Matthew Tontonoz
Previous Page
1 … 12 13 14 15
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute